The Use of a Novel Vaginal Speculum for Cervical Cancer Screening in Sunrise Community Health Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jean Bouquet, DO · PRINCIPAL_INVESTIGATOR · Rocky Vista University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Evaluating the use of the Bouquet Speculum for cervical visibility, ease-of-use, and comfort level3 months
200 women will be selected from the Sunrise Clinics in the Denver-Metro area. The clinician will then be assigned a letter and complete three questions on a survey for each patient regarding 1. visualization of the cervix 2. ease-of-use 3. experience with speculum exams. The patient will be consented and de-identified and assigned a number to their survey of four questions: 1. comfort level 2. last vaginal speculum exam 3. self-reported description of weight (underweight, normal, overweight, obese) 4. parity (number of births). The Bouquet Speculum has been FDA-cleared and is a Class II medical device and poses a non-significant risk for use in humans. Regulation Number: 884.4520